Breast cancer/prostate cancer |
Shiftwork-induced disruption of sleep–wake cycles |
Promotion |
[49–52] |
Excessive calories-induced disruption of eating–fasting cycles |
Promotion |
[53, 54] |
Fasting-induced disruption of eating–fasting cycles |
Inhibition |
[140] [151] |
Exercise-induced disruption of activity–rest cycles |
Inhibition |
[183, 207–210] |
Colorectal cancer |
Short-term fasting-induced disruption of eating–fasting cycles |
Inhibition |
[149–151] |
Maintenance of activity–rest cycles |
Inhibition |
[55, 56] |
Per2 mutation-induced disruption of circadian clock |
Promotion |
[57] |
Lung cancer |
Per2 mutation-induced disruption of circadian clock |
Promotion |
[23] |
Fasting-induced disruption of eating–fasting cycles |
Inhibition |
[383] |
Exercise-induced disruption of activity–rest cycles |
Inhibition |
[412] |
Liver cancer |
Per1/2 mutation or Bmal1 deletion-induced disruption of circadian clock |
Promotion |
[60] |
Acute lymphoblastic leukemia |
Fasting-induced disruption of eating–fasting cycles |
Inhibition |
[167] |
T cell lymphomas |
Cry1/2 or Rorc deletion-induced disruption of circadian clock |
Promotion |
[60, 61] |
Glioma |
Fasting-induced disruption of eating–fasting cycles |
Inhibition |
[141] |
Pancreatic cancer |
Fasting-induced disruption of eating–fasting cycles |
Inhibition |
[166] |
Exercise-induced disruption of activity–rest cycles |
Inhibition |
[426] |